Immune Reconstitution tuberculosis in HIV patients after antiretroviral therapy

JK Science

Volumn 8, Issue 4, 2006, Pages 205-207

  Rajasekaran, S ^a   Vijila, ^a   Ravichandran, N ^a  

^a Government Hospital of Thoracic Medicine   (India)

Author keywords

HIV; Immune Reconstitution Syndrome; Tuberculosis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG COST; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; TUBERCULOUS PLEURISY; TUBERCULOUS SPONDYLITIS;

EID: 33846976748     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Jacobson MA, Zegans M, Pavan PR et al. Cytomegalovirus retinitis after initiation of HAART. Lancet 1997; 349: 1443-45.
2. Race EM, Adelson-Mitty T, Kriegel GR et al. Focal mycobacterial lymphadenitis lollowing initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252.
3. Kumarasamy N, Chaguturu S, Mayer KH et al. Incidence of Immune Reconstitution Syndrome in HIV-Tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J AIDS 2004; 37: 1574-76.
4. Breen RA, Smith CI, Cropley I, Johnson MA, Lipman MC. Does Immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005; 19: 1201-06.
5. Michailidis C, Pozniak AL, Mandalia S, Basnayake S, Nelson MR, Gazzard BG. Clinical Characteristics of IRIS Syndrome in patients with HIV and Tuberculosis. Antivir Ther 2005; 10: 417-22